Caroline Tillett
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Dr. Caroline Tillett is a Chief Scientific Officer at Kenvue, Inc. Dr. Tillett was previously employed as a Vice President-Consumer Research & Development by GSK Plc and a Global Head-Consumer Health by Johnson & Johnson.
She received her undergraduate degree from Kingston University and a doctorate degree from Kingston University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KENVUE, INC. 0 % | 02/03/2026 | 61.448 ( 0 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KENVUE INC. | Director Técnico/Científico/I+D | 01/05/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Kingston University
Kingston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenvue, Inc.
Kenvue, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells healthcare products which includes cosmetics, drugs and medical devices | Consumer Non-Durables |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.